Hennion & Walsh Asset Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,061
| Closed | -$48K | – | 835 |
|
|
2023
Q1 | $48K | Sell |
31,061
-1,063
| -3% | -$1.64K | ﹤0.01% | 772 |
|
|
2022
Q4 | $20K | Sell |
32,124
-46,255
| -59% | -$28.8K | ﹤0.01% | 765 |
|
|
2022
Q3 | $104K | Sell |
78,379
-3,231
| -4% | -$4.29K | 0.01% | 753 |
|
|
2022
Q2 | $181K | Sell |
81,610
-2,893
| -3% | -$6.42K | 0.01% | 731 |
|
|
2022
Q1 | $523K | Sell |
84,503
-1,415
| -2% | -$8.76K | 0.03% | 505 |
|
|
2021
Q4 | $1.08M | Sell |
85,918
-3,501
| -4% | -$44.2K | 0.05% | 338 |
|
|
2021
Q3 | $8.2M | Buy |
89,419
+7,693
| +9% | +$705K | 0.43% | 51 |
|
|
2021
Q2 | $4.33M | Buy |
81,726
+26,317
| +47% | +$1.39M | 0.23% | 108 |
|
|
2021
Q1 | $2M | Buy |
+55,409
| New | +$2M | 0.12% | 230 |
|